JOSHUA ORDWAY: Open Payments
NPI 1285952143 · FRANKLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,881 in 250 payments from 9 companies in 2025. Trend: 2023 $45,639 · 2024 $30,403 · 2025 $65,881
Speaker / faculty: $53,062Consulting: $7,125Food & beverage: $3,704Travel & lodging: $1,990
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 193 | $64,670 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $487 |
| AstraZeneca Pharmaceuticals LP | 7 | $408 |
| Novo Nordisk Inc | 19 | $192 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Corium, LLC | 3 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, UBRELVY, BOTOX, CAPLYTA, AIRSUPRA, Ozempic, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
